Dasashil 20 mg Tablet
  1. Home
  2. Pharma Products
  3. shilpa medicare
  4. Dasashil 20 mg Tablet

Dasashil 20 mg Tablet

Dasashil 20 mg Tablet contains dasatinib 20 mg, a targeted anticancer medicine from the tyrosine kinase inhibitor class. It is used to treat certain types of leukemia, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is taken orally according to the treatment plan prescribed by an oncologist.

BUY NOW

Category

Dasatinib inhibits abnormal tyrosine kinases, including BCR-ABL, which are involved in the growth and survival of certain leukemia cells. Dasashil 20 mg may be used in specific treatment regimens for Philadelphia chromosome-positive leukemia. The tablet can be taken with or without food as directed by the treating physician. Regular medical monitoring may be required during treatment to assess blood counts and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 20 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Tyrosine Kinase Inhibitor
Pack Size 60 tablets

Product Also Known As

Dasashil 20 mg Tablet, Dasashil 20mg Tablet, Dasatinib 20 mg Tablet, Dasatinib 20mg Tablet, Dasatinib Anticancer Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet